Suppr超能文献

嗜酸乳杆菌和双歧杆菌属益生菌的生存及治疗潜力

Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp.

作者信息

Kailasapathy K, Chin J

机构信息

Centre for Advanced Food Research, University of Western Sydney, Hawkesbury, Australia.

出版信息

Immunol Cell Biol. 2000 Feb;78(1):80-8. doi: 10.1046/j.1440-1711.2000.00886.x.

Abstract

The present paper provides an overview on the use of probiotic organisms as live supplements, with particular emphasis on Lactobacillus acidophilus and Bifidobacterium spp. The therapeutic potential of these bacteria in fermented dairy products is dependent on their survival during manufacture and storage. Probiotic bacteria are increasingly used in food and pharmaceutical applications to balance disturbed intestinal microflora and related dysfunction of the human gastrointestinal tract. Lactobacillus acidophilus and Bifidobacterium spp. have been reported to be beneficial probiotic organisms that provide excellent therapeutic benefits. The biological activity of probiotic bacteria is due in part to their ability to attach to enterocytes. This inhibits the binding of enteric pathogens by a process of competitive exclusion. Attachment of probiotic bacteria to cell surface receptors of enterocytes also initiates signalling events that result in the synthesis of cytokines. Probiotic bacteria also exert an influence on commensal micro-organisms by the production of lactic acid and bacteriocins. These substances inhibit growth of pathogens and also alter the ecological balance of enteric commensals. Production of butyric acid by some probiotic bacteria affects the turnover of enterocytes and neutralizes the activity of dietary carcinogens, such as nitrosamines, that are generated by the metabolic activity of commensal bacteria in subjects consuming a high-protein diet. Therefore, inclusion of probiotic bacteria in fermented dairy products enhances their value as better therapeutic functional foods. However, insufficient viability and survival of these bacteria remain a problem in commercial food products. By selecting better functional probiotic strains and adopting improved methods to enhance survival, including the use of appropriate prebiotics and the optimal combination of probiotics and prebiotics (synbiotics), an increased delivery of viable bacteria in fermented products to the consumers can be achieved.

摘要

本文概述了益生菌作为活菌补充剂的用途,特别强调了嗜酸乳杆菌和双歧杆菌属。这些细菌在发酵乳制品中的治疗潜力取决于它们在生产和储存过程中的存活情况。益生菌越来越多地用于食品和制药领域,以平衡紊乱的肠道微生物群以及人类胃肠道的相关功能障碍。据报道,嗜酸乳杆菌和双歧杆菌属是有益的益生菌,具有出色的治疗功效。益生菌的生物活性部分归因于它们附着于肠上皮细胞的能力。这通过竞争排斥过程抑制肠道病原体的结合。益生菌附着于肠上皮细胞的细胞表面受体也会引发信号事件,从而导致细胞因子的合成。益生菌还通过产生乳酸和细菌素对共生微生物产生影响。这些物质抑制病原体的生长,并改变肠道共生菌的生态平衡。一些益生菌产生丁酸会影响肠上皮细胞的更新,并中和饮食致癌物(如亚硝胺)的活性,这些致癌物是由食用高蛋白饮食的受试者体内共生细菌的代谢活动产生的。因此,在发酵乳制品中添加益生菌可提高其作为更好的治疗功能性食品的价值。然而,这些细菌在商业食品中的活力和存活率不足仍然是一个问题。通过选择功能更好的益生菌菌株并采用改进的方法来提高存活率,包括使用合适的益生元以及益生菌和益生元的最佳组合(合生元),可以实现发酵产品中更多的活菌传递给消费者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验